215 related articles for article (PubMed ID: 34368915)
1. Multicentre Performance Evaluation of the Elecsys Anti-SARS-CoV-2 Immunoassay as an Aid in Determining Previous Exposure to SARS-CoV-2.
Riester E; Majchrzak M; Mühlbacher A; Tinguely C; Findeisen P; Hegel JK; Laimighofer M; Rank CM; Schönfeld K; Langen F; Laengin T; Niederhauser C
Infect Dis Ther; 2021 Dec; 10(4):2381-2397. PubMed ID: 34368915
[TBL] [Abstract][Full Text] [Related]
2. Performance evaluation of the Roche Elecsys Anti-SARS-CoV-2 S immunoassay.
Riester E; Findeisen P; Hegel JK; Kabesch M; Ambrosch A; Rank CM; Pessl F; Laengin T; Niederhauser C
J Virol Methods; 2021 Nov; 297():114271. PubMed ID: 34461153
[TBL] [Abstract][Full Text] [Related]
3. Development and Validation of the Elecsys Anti-SARS-CoV-2 Immunoassay as a Highly Specific Tool for Determining Past Exposure to SARS-CoV-2.
Muench P; Jochum S; Wenderoth V; Ofenloch-Haehnle B; Hombach M; Strobl M; Sadlowski H; Sachse C; Torriani G; Eckerle I; Riedel A
J Clin Microbiol; 2020 Sep; 58(10):. PubMed ID: 32747400
[TBL] [Abstract][Full Text] [Related]
4. Recent Advances in the Evaluation of Serological Assays for the Diagnosis of SARS-CoV-2 Infection and COVID-19.
Chiereghin A; Zagari RM; Galli S; Moroni A; Gabrielli L; Venturoli S; Bon I; Rossini G; Saracino IM; Pavoni M; Lafratta S; Deni A; Felici S; Borghi M; Guerra L; Raumer L; Lodi V; Viale P; Attard L; Lazzarotto T;
Front Public Health; 2020; 8():620222. PubMed ID: 33681115
[No Abstract] [Full Text] [Related]
5. Analytical and Clinical Evaluation of the Automated Elecsys Anti-SARS-CoV-2 Antibody Assay on the Roche cobas e602 Analyzer.
Chan CW; Parker K; Tesic V; Baldwin A; Tang NY; van Wijk XMR; Yeo KJ
Am J Clin Pathol; 2020 Oct; 154(5):620-626. PubMed ID: 32814955
[TBL] [Abstract][Full Text] [Related]
6. Comparison of six antibody assays and two combination assays for COVID-19.
Yamamoto M; Okazaki K; Kitai Y; Shinohara K; Yukawa S; Noguchi T; Tanaka M; Matsumura Y; Nishiyama Y; Nagao M
Virol J; 2022 Feb; 19(1):24. PubMed ID: 35115008
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the Elecsys® Anti-SARS-CoV-2 immunoassay with the EDI™ enzyme linked immunosorbent assays for the detection of SARS-CoV-2 antibodies in human plasma.
Egger M; Bundschuh C; Wiesinger K; Gabriel C; Clodi M; Mueller T; Dieplinger B
Clin Chim Acta; 2020 Oct; 509():18-21. PubMed ID: 32485155
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the Clinical Performances of the Abbott Alinity IgG, Abbott Architect IgM, and Roche Elecsys Total SARS-CoV-2 Antibody Assays.
Harley K; Gunsolus IL
J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33106364
[TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of four commercial immunoassays for the detection of antibodies against established SARS-CoV-2 infection.
Chua KYL; Vogrin S; Bittar I; Horvath JH; Wimaleswaran H; Trubiano JA; Holmes NE; Lam Q
Pathology; 2020 Dec; 52(7):778-782. PubMed ID: 33039094
[TBL] [Abstract][Full Text] [Related]
10. Head-to-head comparison of two rapid high-throughput automated electrochemiluminescence immunoassays targeting total antibodies to the SARS-CoV-2 nucleoprotein and spike protein receptor binding domain.
Poljak M; Oštrbenk Valenčak A; Štamol T; Seme K
J Clin Virol; 2021 Apr; 137():104784. PubMed ID: 33711693
[TBL] [Abstract][Full Text] [Related]
11. Specificity testing by point prevalence as a simple assessment strategy using the Roche Elecsys® anti-SARS-CoV-2 immunoassay.
Kittel M; Findeisen P; Muth MC; Thiaucourt M; Gerhards C; Neumaier M; Haselmann V
Int J Infect Dis; 2021 Apr; 105():632-638. PubMed ID: 33578017
[TBL] [Abstract][Full Text] [Related]
12. Head-to-Head Comparison of Two SARS-CoV-2 Serology Assays.
Merrill AE; Jackson JB; Ehlers A; Voss D; Krasowski MD
J Appl Lab Med; 2020 Nov; 5(6):1351-1357. PubMed ID: 32717056
[TBL] [Abstract][Full Text] [Related]
13. Performance of the FREND™ COVID-19 IgG/IgM Duo point-of-care test for SARS-CoV-2 antibody detection.
De Munck DG; Peeters B; Huyghe E; Goossens H; Ieven M; Matheeussen V
Acta Clin Belg; 2022 Jun; 77(3):647-652. PubMed ID: 34152943
[TBL] [Abstract][Full Text] [Related]
14. Performance evaluation of three automated quantitative immunoassays and their correlation with a surrogate virus neutralization test in coronavirus disease 19 patients and pre-pandemic controls.
Jung K; Shin S; Nam M; Hong YJ; Roh EY; Park KU; Song EY
J Clin Lab Anal; 2021 Sep; 35(9):e23921. PubMed ID: 34369009
[TBL] [Abstract][Full Text] [Related]
15. Performance evaluation of Elecsys SARS-CoV-2 Antigen immunoassay for diagnostic of COVID-19.
Montalvo Villalba MC; Sosa Glaria E; Rodriguez Lay LLA; Valdés Ramirez O; Vallina García D; Arencibia Garcia A; Martinez Alfonso J; Menes Llerena DM; Torres Pérez L; Resik Aguirre SR; Guzman Tirado MG
J Med Virol; 2022 Mar; 94(3):1001-1008. PubMed ID: 34676585
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the SARS-CoV-2-IgG response in outpatients by five commercial immunoassays.
Wellinghausen N; Voss M; Ivanova R; Deininger S
GMS Infect Dis; 2020; 8():Doc22. PubMed ID: 32983837
[TBL] [Abstract][Full Text] [Related]
17. Determination of SARS-CoV-2 antibodies with assays from Diasorin, Roche and IDvet.
Krüttgen A; Cornelissen CG; Dreher M; Hornef MW; Imöhl M; Kleines M
J Virol Methods; 2021 Jan; 287():113978. PubMed ID: 32979407
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a New Spike (S)-Protein-Based Commercial Immunoassay for the Detection of Anti-SARS-CoV-2 IgG.
Eberhardt KA; Dewald F; Heger E; Gieselmann L; Vanshylla K; Wirtz M; Kleipass F; Johannis W; Schommers P; Gruell H; Brensing KA; Müller RU; Augustin M; Lehmann C; Koch M; Klein F; Di Cristanziano V
Microorganisms; 2021 Mar; 9(4):. PubMed ID: 33807490
[No Abstract] [Full Text] [Related]
19. Monitoring antibody response following SARS-CoV-2 infection: diagnostic efficiency of 4 automated immunoassays.
Wolff F; Dahma H; Duterme C; Van den Wijngaert S; Vandenberg O; Cotton F; Montesinos I
Diagn Microbiol Infect Dis; 2020 Nov; 98(3):115140. PubMed ID: 32829098
[TBL] [Abstract][Full Text] [Related]
20. Neutralizing antibody responses following natural SARS-CoV-2 infection: Dynamics and correlation with commercial serologic tests.
Montesinos I; Dahma H; Wolff F; Dauby N; Delaunoy S; Wuyts M; Detemmerman C; Duterme C; Vandenberg O; Martin C; Hallin M
J Clin Virol; 2021 Nov; 144():104988. PubMed ID: 34607239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
